Six previously undescribed pyruvate kinase mutations causing enzyme deficiency

被引:33
作者
Demina, A
Varughese, KI
Barbot, J
Forman, L
Beutler, E
机构
[1] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA
[2] Hosp Cent Especializado, Serv Hematol, Porto, Portugal
关键词
D O I
10.1182/blood.V92.2.647.414k13_647_652
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Erythrocyte pyruvate kinase deficiency is the most common cause of hereditary nonspherocytic hemolytic anemia. We present 6 previously undescribed mutations of the PKLR gene associated with enzyme deficiency located at cDNA nt 476 G --> T ((159)Gly --> Val), 884 C --> T ((295)Ala --> Val), 943 G --> A ((315)Glu --> Lys), 1022 G --> A ((341)Gly --> Asp), 1511 G --> T ((504)Arg --> Leu), and 1528 C --> T ((510)Arg --> Ter). Two of these mutations are near the substrate binding site: the (315)Glu --> Lys (943A) mutation may be involved in Mg2+ binding and (159)Gly --> Val (476T) mutation has a possible effect on ADP binding, Four of six mutations produce deduced changes in the shape of the molecule. Two of these mutations, (504)Arg --> Leu (1511T) and (510)Arg --> Ter (1528T), are located at the interface of domains A and C. One of them ((510)Arg --> Ter) is a deletion of the C-terminal residues affecting the integrity of the protein. The (504)Arg --> Leu mutation eliminates a stabilizing interaction between domains A and C. Changes in amino acid 341(nt 1022) from Gly to Asp cause local perturbations. The mutation (295)Ala --> Val (884T) might affect the way pyruvate kinase interacts with other molecules, We review previously described mutations and conclude that there is not yet sufficient data to allow us to draw conclusions regarding genotype/phenotype relationship. (C) 1998 by The American Society of Hematology.
引用
收藏
页码:647 / 652
页数:6
相关论文
共 20 条
[1]   MOLECULAR STUDY OF PYRUVATE-KINASE DEFICIENT PATIENTS WITH HEREDITARY NONSPHEROCYTIC HEMOLYTIC-ANEMIA [J].
BARONCIANI, L ;
BEUTLER, E .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 95 (04) :1702-1709
[2]   STUDY OF THE MOLECULAR DEFECTS IN PYRUVATE-KINASE DEFICIENT PATIENTS AFFECTED BY NONSPHEROCYTIC HEMOLYTIC-ANEMIA [J].
BARONCIANI, L ;
MAGALHAES, LQ ;
MAHONEY, DH ;
WESTWOOD, B ;
ADEKILE, AD ;
LAPPIN, TRJ ;
BEUTLER, E .
BLOOD CELLS MOLECULES AND DISEASES, 1995, 21 (01) :49-55
[3]   Hematologically important mutations: Red cell pyruvate kinase [J].
Baronciani, L ;
Bianchi, P ;
Zanella, A .
BLOOD CELLS MOLECULES AND DISEASES, 1996, 22 (07) :85-89
[4]   G6PD: Population genetics and clinical manifestations [J].
Beutler, E .
BLOOD REVIEWS, 1996, 10 (01) :45-52
[5]   G6PD DEFICIENCY [J].
BEUTLER, E .
BLOOD, 1994, 84 (11) :3613-3636
[6]   FETAL ANEMIA DUE TO PYRUVATE-KINASE DEFICIENCY [J].
GILSANZ, F ;
VEGA, MA ;
GOMEZCASTILLO, E ;
RUIZBALDA, JA ;
OMENACA, F .
ARCHIVES OF DISEASE IN CHILDHOOD-FETAL AND NEONATAL EDITION, 1993, 69 (05) :523-524
[7]  
HENNEKAM R C M, 1990, Genetic Counseling, V1, P75
[8]   IMPROVED METHODS FOR BUILDING PROTEIN MODELS IN ELECTRON-DENSITY MAPS AND THE LOCATION OF ERRORS IN THESE MODELS [J].
JONES, TA ;
ZOU, JY ;
COWAN, SW ;
KJELDGAARD, M .
ACTA CRYSTALLOGRAPHICA SECTION A, 1991, 47 :110-119
[9]   Frame shift mutation, exon skipping, and a two-codon deletion caused by splice site mutations account for pyruvate kinase deficiency [J].
Kanno, H ;
Fujii, H ;
Wei, DC ;
Chan, LC ;
Hirono, A ;
Tsukimoto, I ;
Miwa, S .
BLOOD, 1997, 89 (11) :4213-4218
[10]   MOLSCRIPT - A PROGRAM TO PRODUCE BOTH DETAILED AND SCHEMATIC PLOTS OF PROTEIN STRUCTURES [J].
KRAULIS, PJ .
JOURNAL OF APPLIED CRYSTALLOGRAPHY, 1991, 24 :946-950